| Financial Year |
March 31 2023 |
| Monetary Funds |
1,049,877,212.51 |
| Held-for-trading Financial Assets |
1,144,512,966.53 |
| Notes Receivable |
3,212,891.70 |
| Accounts Receivable |
326,204,037.87 |
| Advances to Suppliers |
36,251,339.67 |
| Other Receivables |
28,947,872.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
535,033,449.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,068,454.02 |
| Total Current Assets |
3,676,278,097.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
74,758,603.05 |
| Investment Properties |
13,857,475.93 |
| Fixed Assetes |
1,225,399,038.57 |
| Under-construction Projects |
44,987,764.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
7,802,947.81 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
184,002,557.12 |
| R&D expenses |
-- |
| Goodwill |
10,691,127.17 |
| Long-Term Deferred and Prepaid Expenses |
8,746,963.01 |
| Deferred Income Tax Assets |
100,616,141.21 |
| Other Non-Current Assets |
500,705,871.65 |
| Sub-Total of Non-Current Assets |
2,190,242,869.53 |
| Total Assets |
5,866,520,967.17 |
| Short-Term Loans |
412,052,715.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
377,949,631.25 |
| Accounts Payable |
339,761,479.50 |
| Accounts Received In Advance |
5,845,848.63 |
| Employee Compensation Payable |
61,223,671.69 |
| Taxes Payable |
57,581,687.30 |
| Interest Payable |
-- |
| Dividend Payable |
5,513,569.56 |
| Other payables |
62,390,523.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,655,373.13 |
| Other Current Liabilities |
18,486,129.58 |
| Sub-Total of Current Liabilities |
1,379,786,975.26 |
| Long-term Loans |
171,360,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
77,409,238.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
259,287,135.87 |
| Total Liabilities |
1,639,074,111.13 |
| Paid-In Capital(Or Share Stock) |
2,305,817,807.00 |
| Capital Surplus |
825,967,811.09 |
| Surplus Reserve |
236,333,678.06 |
| LESS:Treasury Stock |
200,500,573.42 |
| Undistributed Profits |
758,151,521.52 |
| Minority Stockholder's Interest |
303,425,516.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,924,021,339.45 |
| Owner's Equity（Stockholder's Equity） |
4,227,446,856.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,866,520,967.17 |
